## NOC: Northrop Grumman Corporation - XLI: Industrials

### Executive Summary

No thesis match: MRS_10 0.7% below STRENGTH zone (3.0-6.0%); PEG 3.57 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($539.10)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 8, Bearish: 0)

**1. Northrop Wins Deal to Produce High Explosive Proximity for US Army**
- Source: www.sharewise.com | 20251209T160805 | Bullish | Relevance: 99%
- Northrop Grumman has secured a contract exceeding $200 million to produce the XM1211 High Explosive Proximity-fuzed ammunition for the US Army. This advanced round is designed to enhance short-range air defense capabilities, particularly against small unmanned aerial systems. The development, a collaboration with the US Army Joint Program Executive Office for Armaments & Ammunition, strengthens Northrop's position as a leader in innovative ammunition solutions and positions it to benefit from growing global demand for advanced munitions.

**2. Northrop Grumman secures $100 million defense contract for missile systems By Investing.com**
- Source: Investing.com UK | 20251209T222626 | Bullish | Relevance: 99%
-  Northrop Grumman Systems Corporation has been awarded a $100 million contract by the U.S. Department of War for the development and production of missile weapon systems. The contract covers work on Stand-in Attack Weapon and Advanced Anti-Radiation Guided Missile Extended Range systems, including design, development, and testing. This sole-source acquisition is managed by the Air Force Life Cycle Management Center.

**3. State Street Corp Sells 25,962 Shares of Northrop Grumman Corporation $NOC**
- Source: MarketBeat | 20251209T130939 | Neutral | Relevance: 99%
- State Street Corp reduced its stake in Northrop Grumman Corporation (NYSE:NOC) by 0.2% during the second quarter, selling 25,962 shares. Despite this sale, the institutional investor still owned 13,427,807 shares, valued at over $6.7 billion, representing approximately 9.38% of the company. Other institutional investors like Vanguard Group Inc., Soundwatch Capital LLC, and Wellington Management Group LLP increased their holdings in Northrop Grumman during the same period.

**4. Northrop Grumman to build air-to-ground missile with anti-radiation homing for relocatable targets**
- Source: Military Aerospace | 20251211T093633 | Bullish | Relevance: 98%
-  The U.S. Air Force has awarded Northrop Grumman a $100 million contract to continue developing and producing the Stand-in Attack Weapon (SiAW). This precision air-to-ground missile, based on the Navyâ€™s AGM-88G AARGM-ER, is designed to strike high-value, relocatable targets in contested airspace using multi-mode guidance including anti-radiation homing. The SiAW is expected to become operational next year and will be deployed on F-35 and F-16 combat jets.

**5. Northrop Grumman Unveils Project Talon Autonomous Aircraft**
- Source: AdvancedManufacturing.org | 20251209T210729 | Bullish | Relevance: 98%
-  Northrop Grumman has unveiled Project Talon, an autonomous aircraft designed to fly alongside crewed fighters, aiming to revolutionize air dominance. Developed in under 24 months, Project Talon emphasizes speed, simplicity, and advanced modular manufacturing to enhance lethality and mission effectiveness through collaborative aircraft technology. This initiative leverages Northrop Grumman's extensive experience in autonomous systems, further advancing its autonomous portfolio alongside projects like Beacon.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 2 ($0.08M) |
| Sells | 1 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 49.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 9.5% (+0.8%)
- State Street Corpora: 9.3% (-1.6%)
- Capital Internationa: 8.2% (-1.7%)
- Blackrock Inc.: 6.9% (+1.0%)
- JPMORGAN CHASE & CO: 3.9% (+91.5%)

### Key Risks

1. Valuation stretched: PEG 3.6x requires aggressive growth execution.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_10 improving +4.0% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 3.57 signals overvaluation risk, limited margin of safety. Quality metrics strong (ROE 26%). Balance sheet: $1.3B free cash flow. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $80.2B |
| Beta | 0.05 |
| 52W Range | $426.24 - $640.90 |
| Short Interest | 1.2% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.57 |
| Forward P/E | 19.4 |
| Current P/E | 21.5 |
| YoY Growth | 10.6% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from -3.3% to 0.7% (+4.0% in 5 days), confirming momentum buildup. Below STRENGTH zone by 2.3pp (needs >3.0% for momentum thesis). MRS_5 at 1.1% confirms short-term momentum alignment. MACD histogram positive (0.97), confirming momentum. RSI neutral at 47.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 0.72% (CS: 46) | Neutral |
| RSI_14 | 47.0 | Neutral |
| MACD Histogram | 0.97 | Bullish |
| vs SMA20 | 1.001x | Above |
| vs SMA50 | 0.963x | Below |
| vs SMA200 | 1.040x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $560.04
- **Stop Loss:** $539.10 (3.7% risk)
- **Target:** $580.98 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 65
- **Position Value:** $36,402.60
- **Portfolio %:** 36.40%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-01-29 (Est: $6.95)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $6.46 | $7.67 | +18.8% |
| 2025Q2 | $6.80 | $8.15 | +19.9% |
| 2025Q1 | $6.26 | $3.32 | -47.0% |
| 2024Q4 | $6.35 | $6.39 | +0.7% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*